Frederike Waldeck
Overview
Explore the profile of Frederike Waldeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J
BMC Infect Dis
. 2025 Mar;
25(1):318.
PMID: 40050786
Background: Mycoplasma pneumoniae (M. pneumoniae) is a common pathogen of community-acquired pneumonia (CAP). Epidemics occur every 3-7 years especially in pediatric patients. We collected data from a large laboratory network...
2.
Waldeck F, Lemmel S, Panning M, Kading N, Essig A, Rohde G, et al.
Int J Infect Dis
. 2025 Feb;
154:107841.
PMID: 39988242
Objectives: Despite the substantial rates of viral etiology in community-acquired pneumonia (CAP), empirical antibiotic therapy is regularly administered. This study compared the clinical presentation, antibiotic use, and outcomes of patients...
3.
Kading N, Waldeck F, Meier B, Boutin S, Borsche M, Balck A, et al.
Front Public Health
. 2024 Jul;
12:1415778.
PMID: 38979040
Trial Registration: DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418, Registered on 28 October 2020.
4.
Foh B, Schnoor M, Balck A, Waldeck F, Kading N, Borsche M, et al.
ERJ Open Res
. 2023 Jun;
9(4).
PMID: 37362882
https://bit.ly/43x8q6i.
5.
Waldeck F, Seiffert S, Manser S, Zemp D, Walt A, Berger C, et al.
Sci Rep
. 2022 Nov;
12(1):19826.
PMID: 36400917
At our tertiary children's hospital, infections with newly detected methicillin-resistant Staphylococcus aureus (MRSA) among children attending primary (age 6-12 years) and secondary school (age 13-16 years) nearly doubled in 2018...
6.
Waldeck F, Boroli F, Zingg S, Walti L, Wendel-Garcia P, Conen A, et al.
Influenza Other Respir Viruses
. 2022 Nov;
17(1):e13059.
PMID: 36394086
Background: Influenza-associated pulmonary aspergillosis (IAPA) is an important complication of severe influenza with high morbidity and mortality. Methods: We conducted a retrospective multicenter study in tertiary hospitals in Switzerland during...
7.
Balck A, Foh B, Borsche M, Rahmoller J, Vollstedt E, Waldeck F, et al.
BMC Public Health
. 2022 Jul;
22(1):1305.
PMID: 35799167
Background: Considering the insufficiently controlled spread of new SARS-CoV-2 variants, partially low vaccination rates, and increased risk of a post-COVID syndrome, well-functioning, targeted intervention measures at local and national levels...
8.
Fischer T, El Baz Y, Scanferla G, Graf N, Waldeck F, Kleger G, et al.
Eur J Radiol Open
. 2022 Jun;
9:100431.
PMID: 35765661
Purpose: To compare temporal evolution of imaging features of coronavirus disease 2019 (COVID-19) and influenza in computed tomography and evaluate their predictive value for distinction. Methods: In this retrospective, multicenter...
9.
No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza
Studer S, Rassouli F, Waldeck F, Brutsche M, Baty F, Albrich W
Infection
. 2022 Jan;
50(3):699-707.
PMID: 35091985
Purpose: COPD has large impact on patient morbidity and mortality worldwide. Acute exacerbations (AECOPD) are mostly triggered by respiratory infections including influenza. While corticosteroids are strongly recommended in AECOPD, they...
10.
Ziga M, Gianoli D, Waldeck F, Dennler C, Schlichtherle R, Forster T, et al.
Surg Neurol Int
. 2021 Nov;
12:496.
PMID: 34754546
Background: While pyogenic spondylodiscitis due to Gram-positive aerobic bacteria and its treatment is well known, spondylodiscitis caused by anaerobic Gram-negative pathogen is rare. In particular, the spondylodiscitis caused by species...